Literature DB >> 29383594

Detection of alternative subpleural lymph flow pathways using indocyanine green fluorescence.

Aya Harada Takeda1, Yui Watanabe2, Toshiyuki Nagata1, Masaya Aoki1, Tadashi Umehara1, Soichi Suzuki1, Go Kamimura1, Kazuhiro Wakida1, Tsunayuki Otsuka1, Naoya Yokomakura1, Kota Kariatsumari1, Koichi Sakasegawa1, Yoshihiro Nakamura1, Masami Sato1.   

Abstract

PURPOSE: Pulmonary lymphatic fluid predominately flows along the bronchi. However, there are reports suggesting that an alternative lymphatic pathway exist, which may result in skip metastases. The aim of this study was to evaluate the subpleural lymph flow in vivo using indocyanine green (ICG) fluorescence.
METHODS: One hundred cases were enrolled. ICG was injected into the macroscopically healthy subpleural space. Intraoperative fluorescence images were then observed in real time.
RESULTS: ICG fluorescence was observed moving through subpleural channels in 58/100 cases. ICG flowed into adjacent lobes over interlobar lines in 18 cases and flowed from the visceral pleura directly into the mediastinum in 5 cases. The frequency of mediastinal detection without hilar lymph node detection was significantly higher in the left lung compared to the right (p < 0.05). The subpleural lymph flow detection rates were significantly lower in patients with smoking pack-years ≥ 40 than those with < 40 (p < 0.05).
CONCLUSIONS: The flow of lymphatic fluid directly into the mediastinum suggests one mechanism of skip metastasis. In addition, the reduction of the subpleural lymph flows in smokers with ≥ 40 pack-years suggests that smoking might modify lymph flow patterns. These findings may assist in selecting the optimal therapy for patients with possible skip metastasis.

Entities:  

Keywords:  Indocyanine green fluorescence; Lung cancer; Lung remodeling; Skip metastasis; Subpleural lymph flow

Mesh:

Substances:

Year:  2018        PMID: 29383594     DOI: 10.1007/s00595-018-1631-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

1.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping.

Authors:  Sungjee Kim; Yong Taik Lim; Edward G Soltesz; Alec M De Grand; Jaihyoung Lee; Akira Nakayama; J Anthony Parker; Tomislav Mihaljevic; Rita G Laurence; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni
Journal:  Nat Biotechnol       Date:  2003-12-07       Impact factor: 54.908

2.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer.

Authors:  Toshiyuki Kitai; Takuya Inomoto; Mitsuharu Miwa; Takahiro Shikayama
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

3.  Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.

Authors:  Shinichiro Miyoshi; Kazuhiko Shien; Shinichi Toyooka; Kentaroh Miyoshi; Hiromasa Yamamoto; Seiichiro Sugimoto; Junichi Soh; Makio Hayama; Masaomi Yamane; Takahiro Oto
Journal:  Surg Today       Date:  2013-10-31       Impact factor: 2.549

4.  Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non-small cell lung cancer using near-infrared imaging.

Authors:  Denis M Gilmore; Onkar V Khullar; Michael T Jaklitsch; Lucian R Chirieac; John V Frangioni; Yolonda L Colson
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-19       Impact factor: 5.209

5.  Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI).

Authors:  Naoto Nishigori; Fumikazu Koyama; Tadashi Nakagawa; Shinji Nakamura; Takeshi Ueda; Takashi Inoue; Keijirou Kawasaki; Shinsaku Obara; Takayuki Nakamoto; Hisao Fujii; Yoshiyuki Nakajima
Journal:  Ann Surg Oncol       Date:  2015-03-24       Impact factor: 5.344

6.  Is lower zone mediastinal nodal dissection always mandatory for lung cancer in the lower lobe?

Authors:  Hiroyasu Ueno; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-01-27       Impact factor: 2.549

7.  Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.

Authors:  Marc Riquet; Jalal Assouad; Patrick Bagan; Christophe Foucault; Françoise Le Pimpec Barthes; Antoine Dujon; Claire Danel
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

8.  Skip mediastinal nodal metastases in the IIIa/N2 non-small cell lung cancer.

Authors:  Nenad Ilic; Ante Petricevic; Dragan Arar; Slavica Kotarac; Josip Banovic; Nives Frleta Ilic; Andro Tripkovic; Leo Grandic
Journal:  J Thorac Oncol       Date:  2007-11       Impact factor: 15.609

Review 9.  Segmentectomy for c-T1N0M0 non-small cell lung cancer.

Authors:  Hiroaki Nomori
Journal:  Surg Today       Date:  2013-06-29       Impact factor: 2.549

10.  Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.

Authors:  P Misthos; E Sepsas; K Athanassiadi; S Kakaris; I Skottis
Journal:  Eur J Cardiothorac Surg       Date:  2004-04       Impact factor: 4.191

View more
  2 in total

1.  Elevation of Neutrophil-to-Lymphocyte Ratio Is a Significant Poor Prognostic Factor in Completely Resected Centrally Located Lung Squamous Cell Carcinoma.

Authors:  Takuma Tsukioka; Nobuhiro Izumi; Hiroaki Komatsu; Hidetoshi Inoue; Ryuichi Ito; Satoshi Suzuki; Noritoshi Nishiyama
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

2.  Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.

Authors:  Chengyan Zhang; Guanchao Pang; Chengxi Ma; Jingni Wu; Pingli Wang; Kai Wang
Journal:  J Immunol Res       Date:  2019-12-01       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.